China’s Duality Biotherapeutics shares rise more than double in Hong Kong debut
By Scott Murdoch and Donny Kwok SYDNEY (Reuters) -Duality Biotherapeutics stock more than doubled on its Hong Kong debut on Tuesday, achieving the best first-day trading performance following an IPO in the city in four years. The Chinese biotech firm raised $213 million in an initial public offering launched the day financial markets reacted savagely …
China’s Duality Biotherapeutics shares rise more than double in Hong Kong debut Read More »







